Jain Rahul, Evenson Ariana, Jain Rohit, Biddison Elizabeth, Dalal Darshan, Kelly Kathleen M, Karmand Arezo J, Hullsiek Heide, Punnam Jyothi, Plantholt Stephen
Division of Cardiology, Saint Agnes Hospital, Baltimore, MD, USA.
South Med J. 2010 Feb;103(2):131-7. doi: 10.1097/SMJ.0b013e3181c98ff3.
Heart failure (HF) management programs worldwide have reported conflicting outcomes in the past.
We sought to determine retrospectively whether the multidisciplinary outpatient management (MOM) program [heart failure clinic (HFC)], decreased readmission rates (RR), duration of hospital stay, and/or mortality in HF patients.
Records of 138 HF patients who had their first encounter either as admission for HF at St. Agnes Hospital or visit to HFC during the period June 2005 through June 2006 were evaluated for outcomes through September 2007. Twenty-seven patients were followed in the HFC and 111 were in the non-HFC group. During follow up, 39 of the non-HFC group patients crossed over to the HFC group. All baseline parameters, except age (P = 0.006), were similar in both groups.
In the HFC group 4 patients had a total of 5 readmissions, whereas 85 patients had a total of 187 readmissions (P < 0.001) in the non-HFC group. Average lengths of hospitalization were 5.2 +/- 4.8 days and 4.2 +/- 3.2 days (P = 0.18) and the number of readmissions/patient/year was 0.3 and 1.45 (P < 0.001) in the HFC and non-HFC groups, respectively. In the subgroup analysis of cross overs (n = 39), there was a 60% reduction in the readmission rate after crossing over to the HFC group. The significance of decreased mortality in the HFC group could not be assessed due to the small sample size.
The study suggests that the MOM program can significantly reduce RR secondary to HF.
过去全球范围内的心力衰竭(HF)管理项目报告的结果相互矛盾。
我们旨在回顾性确定多学科门诊管理(MOM)项目[心力衰竭诊所(HFC)]是否能降低HF患者的再入院率(RR)、住院时间和/或死亡率。
对2005年6月至2006年6月期间在圣艾格尼丝医院因HF入院或前往HFC首次就诊的138例HF患者的记录进行评估,直至2007年9月的结果。27例患者在HFC接受随访,111例在非HFC组。随访期间,非HFC组的39例患者转入HFC组。两组除年龄外(P = 0.006),所有基线参数相似。
HFC组有4例患者共5次再入院,而非HFC组有85例患者共187次再入院(P < 0.001)。HFC组和非HFC组的平均住院时间分别为5.2±4.8天和4.2±3.2天(P = 0.18),每年每位患者的再入院次数分别为0.3次和1.45次(P < 0.001)。在交叉亚组分析(n = 39)中,转入HFC组后再入院率降低了60%。由于样本量小,无法评估HFC组死亡率降低的显著性。
该研究表明,MOM项目可显著降低HF继发的RR。